| Literature DB >> 35953729 |
Mellar Davis1, Charles Loprinzi2.
Abstract
Chemotherapy-induced neuropathy is difficult to manage, and the pain associated with neuropathy is poorly responsive to gabapentin in a randomized trial. Duloxetine is the only drug that has been found to be effective in reducing pain from chemotherapy neuropathy. In this qualitative review, the use of pregabalin for chemotherapy-induced neuropathy is discussed including the rationale and pharmacological reasons why pregabalin should be considered in a large, randomized placebo-controlled trial.Entities:
Keywords: Alpha2dellta; Calcium channel; Chemotherapy; Neuropathy; Pain; Pregabalin
Year: 2022 PMID: 35953729 DOI: 10.1007/s00520-022-07317-7
Source DB: PubMed Journal: Support Care Cancer ISSN: 0941-4355 Impact factor: 3.359